Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose

J Hepatol. 1994 Feb;20(2):307-9. doi: 10.1016/s0168-8278(05)80076-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Chronic Disease
  • Female
  • Hepatitis B / drug therapy
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Humans
  • Male
  • Middle Aged
  • Serum Albumin / pharmacology*
  • Serum Albumin / therapeutic use
  • Vidarabine Phosphate / pharmacology*
  • Vidarabine Phosphate / therapeutic use
  • Virus Replication / drug effects*

Substances

  • Serum Albumin
  • lactosaminated serum albumin
  • Vidarabine Phosphate